BestTreat

BestTreat is dedicated to advancing higher education and research, particularly focusing on groundbreaking work in understanding Non-Alcoholic Fatty Liver Disease (NAFLD) and the critical role of the gut microbiome. Through innovative approaches and collaborative efforts, BestTreat aims to contribute significantly to the scientific community and improve outcomes in clinical nutrition.

With expertise in genetic engineering, bioinformatics, and clinical nutrition, BestTreat is at the forefront of cutting-edge research. Funded by the H2020 EU project under grant agreement 813781, BestTreat exemplifies a commitment to excellence and innovation in higher education and scientific discovery. The company is dedicated to fostering a deeper understanding of complex health issues and developing advanced solutions.

BestTreat continues to expand its research initiatives and educational programs. The company is committed to making significant contributions to the field. We invite the management team at BestTreat to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.